Markets · 1 sources covering this

Marvell’s stock has soared ahead of earnings. Why analysts say it’s still ‘underestimated.’

The company’s leadership in optical connectivity and the ramp-up of custom chips should deliver a strong quarter, according to analysts.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

MarketWatchCenter·2h ago
Marvell’s stock has soared ahead of earnings. Why analysts say it’s still ‘underestimated.’
The company’s leadership in optical connectivity and the ramp-up of custom chips should deliver a strong quarter, according to analysts.
Read at MarketWatch →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/eb0a19351f5d03ea7c283a18711037f0870d1d1e"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Marvell&#x2019;s stock has soared ahead of earnings. Why analysts say it&#x2019;s still &#x2018;underestimated.&#x2019;"></iframe>

Marvell’s stock has soared ahead of earnings. Why analysts say it’s still ‘underestimated.’

How 1 sources are covering this

Marvell’s stock has soared ahead of earnings. Why analysts say it’s still ‘underestimated.’

More from Markets

Cancer treatment already costs hundreds of thousands of dollars — and it’s about to get even worse

This bear market signal Wall Street ignores is putting your money at risk right now

Strait of Hormuz Traffic Fades to a Crawl After Supertankers Exit

Micron investors are partying like it’s 1987. Analysts say the stock still looks pretty cheap.

Reader

Trust & legal

Across the network

How 1 sources are covering this

Marvell&#x2019;s stock has soared ahead of earnings. Why analysts say it&#x2019;s still &#x2018;underestimated.&#x2019;

More from Markets

Cancer treatment already costs hundreds of thousands of dollars &#x2014; and it&#x2019;s about to get even worse

This bear market signal Wall Street ignores is putting your money at risk right now

Strait of Hormuz Traffic Fades to a Crawl After Supertankers Exit

Micron investors are partying like it&#x2019;s 1987. Analysts say the stock still looks pretty cheap.

Reader

Trust & legal

Across the network

Marvell’s stock has soared ahead of earnings. Why analysts say it’s still ‘underestimated.’

Cancer treatment already costs hundreds of thousands of dollars — and it’s about to get even worse

Micron investors are partying like it’s 1987. Analysts say the stock still looks pretty cheap.